It will be impossible unless one of the currect ongoing trials is approved.To consult and operate another biotech company seeking approval for A/D is great for mankind but to me is a total conflict of interest even if one has rights to Intellect.
I take Chain as the chief scientist/merger or anyone in that field that is qualified to lead the science but imo without a scientist unless one of the trials are approved we in deep deep deep trouble on out into the future.
Something will occur this summer good bad or ugly!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.